What is LOPJLB’s current signal on DARE?

LOPJLB’s latest quantitative signal on Dare Bioscience, Inc. (DARE) is BUY in a CRISIS regime. Signals are updated daily.

What market regime is DARE in?

Dare Bioscience, Inc. (DARE) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Dare Bioscience, Inc. based / listed?

Dare Bioscience, Inc. is based in US, listed on NASDAQ.

Dare Bioscience, Inc. (DARE)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.77-2.53%Close

BUYCRISIS · day 1

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $7M
Beta: 1.01
P/E (TTM): -1.06

Short % float: 9.17%
Days to cover: 3.2
SI change: -12.0%

1W: -9.41%
1M: +6.94%

vs SPY 1W: -10.97%
vs SPY 1M: +5.18%

Industry peers

FMP comparable companies · ranked by market cap

ANLSELLAdlai Nortye Ltd.$823MRECOVERYQ 15$15.51+10.39%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

DarÃ© Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial…

Employees: 23
Headquarters: US
Founded: 2014
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 9.5M
Float: 98.4%

darebioscience.com ↗

Key executives

Sabrina Martucci Johnson — Chief Executive Officer, President, Principal Financial Officer, Secretary & Director

MarDee J. Haring-Layton — Chief Accounting Officer

Jennifer Kiang — Vice President of Corporate Affairs & Development

SEC filings

EDGAR · CIK 14019140 · DARE

Analyst consensus

Buy

Bullish6100.0%

Neutral00.0%

Bearish00.0%

L $1.00Avg $1.00H $1.00

Target$1.00+29.87%

Last$0.77

Key stats

Industry peers

Prediction markets

Company news